Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63


18F-FDG PET/CT findings in hepatosplenic Gamma-Delta T-cell lymphoma: case reports and review of the literature.

Cho MW, Chin BB.

Am J Nucl Med Mol Imaging. 2018 Apr 25;8(2):137-142. eCollection 2018.


Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.

Pan R, Qin Y, Banasik M, Lees W, Shepherd AJ, Cho MW, Kong XP.

J Virol. 2018 Mar 14;92(7). pii: e01894-17. doi: 10.1128/JVI.01894-17. Print 2018 Apr 1.


Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy.

Nabi R, Moldoveanu Z, Wei Q, Golub ET, Durkin HG, Greenblatt RM, Herold BC, Nowicki MJ, Kassaye S, Cho MW, Pinter A, Landay AL, Mestecky J, Kozlowski PA.

PLoS One. 2017 Jul 3;12(7):e0180245. doi: 10.1371/journal.pone.0180245. eCollection 2017.


Transient Biocompatible Polymeric Platforms for Long-Term Controlled Release of Therapeutic Proteins and Vaccines.

Acar H, Banerjee S, Shi H, Jamshidi R, Hashemi N, Cho MW, Montazami R.

Materials (Basel). 2016 May;9(5). pii: 321. doi: 10.3390/ma9050321. Epub 2016 Apr 28.


Comparison of the vaginal environment in rhesus and cynomolgus macaques pre- and post-lactobacillus colonization.

Daggett GJ Jr, Zhao C, Connor-Stroud F, Oviedo-Moreno P, Moon H, Cho MW, Moench T, Anderson DJ, Villinger F.

J Med Primatol. 2017 Oct;46(5):232-238. doi: 10.1111/jmp.12264. Epub 2017 May 9.


Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.

Banerjee S, Shi H, Banasik M, Moon H, Lees W, Qin Y, Harley A, Shepherd A, Cho MW.

Virology. 2017 May;505:113-126. doi: 10.1016/j.virol.2017.02.015. Epub 2017 Feb 23.


Focal Breast Pain: Does Breast Density Affect the Need for Ultrasound?

Cho MW, Grimm LJ, Johnson KS.

Acad Radiol. 2017 Jan;24(1):53-59. doi: 10.1016/j.acra.2016.09.004. Epub 2016 Oct 13.


Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody Responses.

Vela Ramirez JE, Tygrett LT, Hao J, Habte HH, Cho MW, Greenspan NS, Waldschmidt TJ, Narasimhan B.

J Biomed Nanotechnol. 2016 Jun;12(6):1303-11.


Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.

Banerjee S, Shi H, Habte HH, Qin Y, Cho MW.

Virology. 2016 Mar;490:17-26. doi: 10.1016/j.virol.2016.01.002. Epub 2016 Jan 21.


Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.

Habte HH, Banerjee S, Shi H, Qin Y, Cho MW.

Virology. 2015 Dec;486:187-97. doi: 10.1016/j.virol.2015.09.010. Epub 2015 Oct 9.


Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop.

Qin Y, Banerjee S, Agrawal A, Shi H, Banasik M, Lin F, Rohl K, LaBranche C, Montefiori DC, Cho MW.

PLoS One. 2015 Jun 3;10(6):e0128823. doi: 10.1371/journal.pone.0128823. eCollection 2015.


Detailed characterization of antibody responses against HIV-1 group M consensus gp120 in rabbits.

Qin Y, Shi H, Banerjee S, Agrawal A, Banasik M, Cho MW.

Retrovirology. 2014 Dec 20;11:125. doi: 10.1186/s12977-014-0125-5.


Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.

Vela Ramirez JE, Roychoudhury R, Habte HH, Cho MW, Pohl NL, Narasimhan B.

J Biomater Sci Polym Ed. 2014;25(13):1387-406. doi: 10.1080/09205063.2014.940243. Epub 2014 Jul 28.


Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence.

Qin Y, Banasik M, Kim S, Penn-Nicholson A, Habte HH, LaBranche C, Montefiori DC, Wang C, Cho MW.

Virology. 2014 Aug;462-463:363-76. doi: 10.1016/j.virol.2014.06.006.


Factors associated with failure of enhanced recovery protocol in patients undergoing major hepatobiliary and pancreatic surgery: a retrospective cohort study.

Lee A, Chiu CH, Cho MW, Gomersall CD, Lee KF, Cheung YS, Lai PB.

BMJ Open. 2014 Jul 10;4(7):e005330. doi: 10.1136/bmjopen-2014-005330.


A model for the receptive field of retinal ganglion cells.

Cho MW, Choi MY.

Neural Netw. 2014 Jan;49:51-8. doi: 10.1016/j.neunet.2013.09.005. Epub 2013 Sep 27.


Spontaneous organization of the cortical structure through endogenous neural firing and gap junction transmission.

Cho MW, Choi MY.

Neural Netw. 2012 Jul;31:46-52. doi: 10.1016/j.neunet.2012.03.002. Epub 2012 Mar 16.


Radiology case of the month: 11-year-old girl with intramuscular hemangioma. Intramuscular hemangioma within the right soleus muscle.

Cho MW, Johnston S, Neitzschman HR.

J La State Med Soc. 2011 Jul-Aug;163(4):234, 236. No abstract available.


HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA).

Hioe CE, Tuen M, Vasiliver-Shamis G, Alvarez Y, Prins KC, Banerjee S, NĂ¡das A, Cho MW, Dustin ML, Kachlany SC.

PLoS One. 2011;6(8):e23202. doi: 10.1371/journal.pone.0023202. Epub 2011 Aug 5.


How can vaccines against influenza and other viral diseases be made more effective?

Nara PL, Tobin GJ, Chaudhuri AR, Trujillo JD, Lin G, Cho MW, Levin SA, Ndifon W, Wingreen NS.

PLoS Biol. 2010 Dec 21;8(12):e1000571. doi: 10.1371/journal.pbio.1000571. No abstract available.


Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry.

Wang L, Qin Y, Ilchenko S, Bohon J, Shi W, Cho MW, Takamoto K, Chance MR.

Biochemistry. 2010 Oct 26;49(42):9032-45. doi: 10.1021/bi1011332.


Structural characterization of HIV gp41 with the membrane-proximal external region.

Shi W, Bohon J, Han DP, Habte H, Qin Y, Cho MW, Chance MR.

J Biol Chem. 2010 Jul 30;285(31):24290-8. doi: 10.1074/jbc.M110.111351. Epub 2010 Jun 4.


Human immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapse.

Vasiliver-Shamis G, Cho MW, Hioe CE, Dustin ML.

J Virol. 2009 Nov;83(21):11341-55. doi: 10.1128/JVI.01440-09. Epub 2009 Aug 26.


Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells.

Vasiliver-Shamis G, Tuen M, Wu TW, Starr T, Cameron TO, Thomson R, Kaur G, Liu J, Visciano ML, Li H, Kumar R, Ansari R, Han DP, Cho MW, Dustin ML, Hioe CE.

J Virol. 2008 Oct;82(19):9445-57. doi: 10.1128/JVI.00835-08. Epub 2008 Jul 16.


Micro Dot Patterning on the Light Guide Panel Using Powder Blasting.

Jang HS, Cho MW, Park DS.

Sensors (Basel). 2008 Feb 8;8(2):877-885.


Micro Fluidic Channel Machining on Fused Silica Glass Using Powder Blasting.

Jang HS, Cho MW, Park DS.

Sensors (Basel). 2008 Feb 6;8(2):700-710.


Equalization of synaptic efficacy by synchronous neural activity.

Cho MW, Choi MY.

Phys Rev Lett. 2007 Nov 16;99(20):208102. Epub 2007 Nov 13. Erratum in: Phys Rev Lett. 2008 Jun 6;100(22):229901.


Application of Design of Experiment Method for Thrust Force Minimization in Step-feed Micro Drilling.

Kim DW, Cho MW, Seo TI, Lee ES.

Sensors (Basel). 2008 Jan 21;8(1):211-221.


Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope.

Penn-Nicholson A, Han DP, Kim SJ, Park H, Ansari R, Montefiori DC, Cho MW.

Virology. 2008 Mar 15;372(2):442-56. Epub 2007 Dec 19.


Magnetostrictive Micro Mirrors for an Optical Switch Matrix.

Lee HS, Cho C, Cho MW.

Sensors (Basel). 2007 Oct 9;7(10):2174-2182. doi: 10.3390/s7102174.


Selective growth of vertically-aligned ZnO nano-needles.

Lee SH, Lee WH, Lee S, Goto H, Baba T, Cho MW, Yao T, Lee HJ, Yasukawa T, Matsue T, Ko H.

J Nanosci Nanotechnol. 2006 Nov;6(11):3351-4.


Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.

Han DP, Penn-Nicholson A, Cho MW.

Virology. 2006 Jun 20;350(1):15-25. Epub 2006 Feb 28.


Control of the ZnO nanowires nucleation site using microfluidic channels.

Lee SH, Lee HJ, Oh D, Lee SW, Goto H, Buckmaster R, Yasukawa T, Matsue T, Hong SK, Ko H, Cho MW, Yao T.

J Phys Chem B. 2006 Mar 9;110(9):3856-9.


Novel method for site-controlled surface nanodot fabrication by ion beam synthesis.

Buckmaster R, Hanada T, Kawazoe Y, Cho MW, Yao T, Urushihara N, Yamamoto A.

Nano Lett. 2005 Apr;5(4):771-6.


Different ocular dominance map formation influenced by orientation preference columns in visual cortices.

Cho MW, Kim S.

Phys Rev Lett. 2005 Feb 18;94(6):068701. Epub 2005 Feb 16.


Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein.

Han DP, Kim HG, Kim YB, Poon LL, Cho MW.

Virology. 2004 Aug 15;326(1):140-9.


Understanding visual map formation through vortex dynamics of spin Hamiltonian models.

Cho MW, Kim S.

Phys Rev Lett. 2004 Jan 9;92(1):018101. Epub 2004 Jan 5.


Subunit protein vaccines: theoretical and practical considerations for HIV-1.

Cho MW.

Curr Mol Med. 2003 May;3(3):243-63. Review.


Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.

Cho MW, Kim YB, Lee MK, Gupta KC, Ross W, Plishka R, Buckler-White A, Igarashi T, Theodore T, Byrum R, Kemp C, Montefiori DC, Martin MA.

J Virol. 2001 Mar;75(5):2224-34.


Production of HIV-1 gp120 in packed-bed bioreactor using the vaccinia virus/T7 expression system.

Hu YC, Kaufman J, Cho MW, Golding H, Shiloach J.

Biotechnol Prog. 2000 Sep-Oct;16(5):744-50.


Assessment of HIV vaccine development: past, present, and future.

Cho MW.

Adv Pharmacol. 2000;49:263-314. Review. No abstract available.


Higher western blot immunoreactivity of glycoprotein 120 from R5 HIV type 1 isolates compared with X4 and X4R5 isolates.

Lee MK, Martin MA, Cho MW.

AIDS Res Hum Retroviruses. 2000 May 20;16(8):765-75.


Supplemental Content

Support Center